Citalopram Hydrobromide

규격

59729-32-7CAS 번호

261-890-6EC 번호

1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;hydrobromideIUPAC 명칭

C20H22BrFN2O화학식

405.3 g/mol분자량

citalopram hydrobromide; 59729-32-7; Citalopram HBr; Seropram; Elopram; Lu 10-171-B; Citalopram (as hydrobromide); NSC-758684; I1E9D14F36; LU-10-171-B; DTXSID40872344; 1-(3-(dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile monohydrobromide; 5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, monohydrobromide; Perrigo citalopram; Paxoran; RefChem:54834; 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile monohydrobromide; 3-(5-cyano-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-1-yl)-N,N-dimethylpropan-1-aminium bromide; CHEBI:3724; DTXCID60819993; 261-890-6; Celexa; 1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrobromide; CITALOPRAM, HYDROBROMIDE SALT; C20H22BrFN2O; MFCD02101306; (S)-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrobromide; Citalopram (hydrobromide); 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile hydrobromide; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;hydrobromide; Nitalapram HBr; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile hydrobromide; SMR000326936; Citalopram hydrobromide [USAN]; Lu-10-171; SR-01000003129; 1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile monohydrobromide; EINECS 261-890-6; Apertia; Prisdal; Lupram; Sepram; UNII-I1E9D14F36; Bonitrile HBr; Prepram HBr; 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Hydrobromide; Citalopram hydrobromide [USAN:USP]; Celexa (TN); CPD000326936; 59729-32-7 (HBr); Citalopram hydrobromide CRS; SCHEMBL1118; SCHEMBL41352; MLS000758293; MLS000860078; MLS001401376; MLS002222294; Citalopram hydrobromide (USP); Lu 10-171 HBr; orb1224532; orb1308515; CHEMBL1200781; HY-B1287R; MSK10296A; GLXC-07937; HMS5083H04; Pharmakon1600-01504172; Citalopram HBr - Bio-X trade mark; HY-B1287; Lu-10-171B; CITALOPRAM HYDROBROMIDE [MI]; Tox21_500258; Citalopram (hydrobromide) (Standard); EBC-12781; HB2142; NSC758684; s4749; ZD 211; ZD-211; Citalopram for system suitability CRS; CITALOPRAM HYDROBROMIDE [HSDB]; AKOS005145738; AB10921; AC-1595; CCG-101022; CCG-213271; CITALOPRAM HYDROBROMIDE [MART.]; CITALOPRAM HYDROBROMIDE [VANDF]; CS-4735; FC64980; KS-1043; LP00258; NC00272; NSC 758684; CITALOPRAM HYDROBROMIDE [USP-RS]; CITALOPRAM HYDROBROMIDE [WHO-DD]; NCGC00093717-01; NCGC00093717-02; NCGC00093717-03; NCGC00260943-01; BC164316; Citalopram hydrobromide, >=98% (HPLC); SY076381; C2370; CITALOPRAM HYDROBROMIDE [ORANGE BOOK]; EU-0100258; NS00088112; CITALOPRAM HYDROBROMIDE [EP MONOGRAPH]; CITALOPRAM HYDROBROMIDE [USP IMPURITY]; C 7861; C75790; Citalopram Hydrobromide (1 mg/mL in Methanol); CITALOPRAM HYDROBROMIDE [USP MONOGRAPH]; D00822; EN300-122615; SBI-0050246.0001; F047248; Citalopram hydrobromide 100 |Ig/mL in Acetonitrile; Citalopram.HBr, 1mg/ml in Methanol (as free base); SR-01000003129-2; SR-01000003129-4; Citalopram hydrobromide 100 microg/mL in Acetonitrile; Q27280253; SR-01000003129-10; Z1550648760; Citalopram Hydrobromide 0.1 mg/ml in Methanol (as free base); Citalopram Hydrobromide 1.0 mg/ml in Methanol (as free base); Citalopram hydrobromide, European Pharmacopoeia (EP) Reference Standard; Citalopram hydrobromide, United States Pharmacopeia (USP) Reference Standard; 1-(3-(DIMETHYLAMINO)PROPYL)-1-(P-FLUOROPHENYL)-5-PHTHALANCARBONITRILE MONOHBR; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile;hydrobromide; Citalopram for system suitability, European Pharmacopoeia (EP) Reference Standard; Citalopram Hydrobromide, Pharmaceutical Secondary Standard; Certified Reference Material; 1-(3-Dimethylamino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile hydrobromide; 1-(3-DIMETHYLAMINOPROPYL)-1-(4'-FLUOROPHENYL)-1, 3-DIHYDROISOBENZOFURAN-5-CARBONITRILE HBR; 1-(3-DIMETHYLAMINOPROPYL)-1-(4'-FLUOROPHENYL)-1, 3-DIHYDROISOBENZOFURAN-5-CARBONITRILE HYDROBROMIDE; 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile--hydrogen bromide (1/1); 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitril e hydrobromide; 5-ISOBENZOFURANCARBONITRILE, 1-(3-(DIMETHYLAMINO)PROPYL)-1-(4-FLUOROPHENYL)-1,3-DIHYDRO-, MONOHBR; 5-ISOBENZOFURANCARBONITRILE, 1-[3-(DIMETHYLAMINO)PROPYL]-1-(4-FLUOROPHENYL)-1,3-DIHYDRO-, HYDROBROMIDE (1:1); Nitalapram, LU-10-171, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dizohydro-5-isobenzofurancar bonitrile hydrobromide salt동의어